(firstQuint)Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer.

 This is a multi-centre, observational, non-interventional study.

 Patients with metastatic colorectal cancer eligible for Bevacizumab in combination with chemotherapy treatment will be enrolled in this trial.

.

 Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer@highlight

To assess the safety profile of bevacizumab in combination with chemotherapy for the treatment of metastatic colorectal cancer